Immunosuppressive Agents—Effects on the Cardiovascular System and Selected Metabolic Aspects: A Review
The widespread use of immunosuppressive drugs makes it possible to reduce inflammation in autoimmune diseases, as well as prevent transplant rejection in organ recipients. Despite their key action in blocking the body’s immune response, these drugs have many side effects. These actions primarily aff...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-11-01
|
| Series: | Journal of Clinical Medicine |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2077-0383/12/21/6935 |
| _version_ | 1797631727841050624 |
|---|---|
| author | Bianka Opałka Michał Żołnierczuk Marta Grabowska |
| author_facet | Bianka Opałka Michał Żołnierczuk Marta Grabowska |
| author_sort | Bianka Opałka |
| collection | DOAJ |
| description | The widespread use of immunosuppressive drugs makes it possible to reduce inflammation in autoimmune diseases, as well as prevent transplant rejection in organ recipients. Despite their key action in blocking the body’s immune response, these drugs have many side effects. These actions primarily affect the cardiovascular system, and the incidence of complications in patients using immunosuppressive drugs is significant, being associated with a higher incidence of cardiovascular incidents such as myocardial infarction and stroke. This paper analyzes the mechanisms of action of commonly used immunosuppressive drugs and their impact on the cardiovascular system. The adverse effect of immunosuppressive drugs is associated with toxicity within the cardiovascular system, which may be a problem in the clinical management of patients after transplantation. Immunosuppressants act on the cardiovascular system in a variety of ways, including fibrosis and myocardial remodeling, endothelium disfunction, hypertension, atherosclerosis, dyslipidemia or hyperglycaemia, metabolic syndrome, and hyperuricemia. The use of multidrug protocols makes it possible to develop regimens that can reduce the incidence of cardiovascular events. A better understanding of their mechanism of action and the range of complications could enable physicians to select the appropriate therapy for a given patient, as well as to reduce complications and prolong life. |
| first_indexed | 2024-03-11T11:26:23Z |
| format | Article |
| id | doaj.art-7d3a355d3653446b856f805188fd67e6 |
| institution | Directory Open Access Journal |
| issn | 2077-0383 |
| language | English |
| last_indexed | 2024-03-11T11:26:23Z |
| publishDate | 2023-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Journal of Clinical Medicine |
| spelling | doaj.art-7d3a355d3653446b856f805188fd67e62023-11-10T15:06:57ZengMDPI AGJournal of Clinical Medicine2077-03832023-11-011221693510.3390/jcm12216935Immunosuppressive Agents—Effects on the Cardiovascular System and Selected Metabolic Aspects: A ReviewBianka Opałka0Michał Żołnierczuk1Marta Grabowska2Department of Histology and Developmental Biology, Faculty of Health Sciences, Pomeranian Medical University, 71-210 Szczecin, PolandDepartment of Plastic, Endocrine and General Surgery, Pomeranian Medical University, 72-010 Szczecin, PolandDepartment of Histology and Developmental Biology, Faculty of Health Sciences, Pomeranian Medical University, 71-210 Szczecin, PolandThe widespread use of immunosuppressive drugs makes it possible to reduce inflammation in autoimmune diseases, as well as prevent transplant rejection in organ recipients. Despite their key action in blocking the body’s immune response, these drugs have many side effects. These actions primarily affect the cardiovascular system, and the incidence of complications in patients using immunosuppressive drugs is significant, being associated with a higher incidence of cardiovascular incidents such as myocardial infarction and stroke. This paper analyzes the mechanisms of action of commonly used immunosuppressive drugs and their impact on the cardiovascular system. The adverse effect of immunosuppressive drugs is associated with toxicity within the cardiovascular system, which may be a problem in the clinical management of patients after transplantation. Immunosuppressants act on the cardiovascular system in a variety of ways, including fibrosis and myocardial remodeling, endothelium disfunction, hypertension, atherosclerosis, dyslipidemia or hyperglycaemia, metabolic syndrome, and hyperuricemia. The use of multidrug protocols makes it possible to develop regimens that can reduce the incidence of cardiovascular events. A better understanding of their mechanism of action and the range of complications could enable physicians to select the appropriate therapy for a given patient, as well as to reduce complications and prolong life.https://www.mdpi.com/2077-0383/12/21/6935immunosuppressive therapyside effectscardiovascular system |
| spellingShingle | Bianka Opałka Michał Żołnierczuk Marta Grabowska Immunosuppressive Agents—Effects on the Cardiovascular System and Selected Metabolic Aspects: A Review Journal of Clinical Medicine immunosuppressive therapy side effects cardiovascular system |
| title | Immunosuppressive Agents—Effects on the Cardiovascular System and Selected Metabolic Aspects: A Review |
| title_full | Immunosuppressive Agents—Effects on the Cardiovascular System and Selected Metabolic Aspects: A Review |
| title_fullStr | Immunosuppressive Agents—Effects on the Cardiovascular System and Selected Metabolic Aspects: A Review |
| title_full_unstemmed | Immunosuppressive Agents—Effects on the Cardiovascular System and Selected Metabolic Aspects: A Review |
| title_short | Immunosuppressive Agents—Effects on the Cardiovascular System and Selected Metabolic Aspects: A Review |
| title_sort | immunosuppressive agents effects on the cardiovascular system and selected metabolic aspects a review |
| topic | immunosuppressive therapy side effects cardiovascular system |
| url | https://www.mdpi.com/2077-0383/12/21/6935 |
| work_keys_str_mv | AT biankaopałka immunosuppressiveagentseffectsonthecardiovascularsystemandselectedmetabolicaspectsareview AT michałzołnierczuk immunosuppressiveagentseffectsonthecardiovascularsystemandselectedmetabolicaspectsareview AT martagrabowska immunosuppressiveagentseffectsonthecardiovascularsystemandselectedmetabolicaspectsareview |